Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Exclusive Ideagen Ideas Leader Interview with Anthony Magnetti - Sunovion

  • Broadcast in News
  • 0 comments
Ideagen Radio

Ideagen Radio

×  

Follow This Show

If you liked this show, you should follow Ideagen Radio.
h:582621
s:7736285
archived

Anthony J. Magnetti

Sunovion Pharmaceuticals Inc.

Anthony Magnetti is a seasoned pharmaceutical executive with more than 40 years of experience that spans Government Affairs, Medical Affairs, Clinical Research Services, and Sales and Marketing.

Currently, Mr. Magnetti leads Government Affairs for Sunovion Pharmaceuticals Inc., which focuses on therapies that advance the science of medicine in the psychiatry, neurology and respiratory disease areas to improve the lives of patients and their families.

In this role Mr. Magnetti is responsible for addressing public policy and regulatory areas important to the company’s therapeutic areas of focus and the patients it serves. He has led several initiatives focused on preserving and expanding access to medicines and services that patients need. Over the last five years, Mr. Magnetti has helped enable the introduction and passage of numerous pieces of legislation putting patient protections into law, and has guided efforts to codify the six protected classes in Medicare Part D. Under his leadership, the Government Affairs team supports leading advocacy, educational, and cross-sector coalitions focused on the advancement of research and innovation, as well as improvements in healthcare.

Mr. Magnetti joined the company in 1997 and in addition to Government Affairs has held increasingly senior roles across various functions including building and leading the Respiratory and Central Nervous System Medical Liaison Teams for Sunovion. 

Mr. Magnetti holds a Bachelor’s degree in Biology from the State University of New York Albany. He serves on executive committees at Sunovion, as well as on several committees of biopharmaceutical industry organizations. 

Comments

 comments